265 related articles for article (PubMed ID: 7954427)
1. Loss of Apc+ in intestinal adenomas from Min mice.
Luongo C; Moser AR; Gledhill S; Dove WF
Cancer Res; 1994 Nov; 54(22):5947-52. PubMed ID: 7954427
[TBL] [Abstract][Full Text] [Related]
2. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induces genetic changes in murine intestinal tumours and cells with ApcMin mutation.
Andreassen A; Vikse R; Mikalsen A; Adamovic T; Steffensen IL; Hjertholm H; Levan G; Alexander J
Mutat Res; 2006 Apr; 604(1-2):60-70. PubMed ID: 16574467
[TBL] [Abstract][Full Text] [Related]
3. The intestinal epithelium and its neoplasms: genetic, cellular and tissue interactions.
Dove WF; Cormier RT; Gould KA; Halberg RB; Merritt AJ; Newton MA; Shoemaker AR
Philos Trans R Soc Lond B Biol Sci; 1998 Jun; 353(1370):915-23. PubMed ID: 9684289
[TBL] [Abstract][Full Text] [Related]
4. Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice.
Sieber OM; Howarth KM; Thirlwell C; Rowan A; Mandir N; Goodlad RA; Gilkar A; Spencer-Dene B; Stamp G; Johnson V; Silver A; Yang H; Miller JH; Ilyas M; Tomlinson IP
Cancer Res; 2004 Dec; 64(24):8876-81. PubMed ID: 15604247
[TBL] [Abstract][Full Text] [Related]
5. MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis.
Reitmair AH; Cai JC; Bjerknes M; Redston M; Cheng H; Pind MT; Hay K; Mitri A; Bapat BV; Mak TW; Gallinger S
Cancer Res; 1996 Jul; 56(13):2922-6. PubMed ID: 8674041
[TBL] [Abstract][Full Text] [Related]
6. Interaction between murine germline mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy.
Clarke AR; Cummings MC; Harrison DJ
Oncogene; 1995 Nov; 11(9):1913-20. PubMed ID: 7478622
[TBL] [Abstract][Full Text] [Related]
7. Expression of guanylin is downregulated in mouse and human intestinal adenomas.
Steinbrecher KA; Tuohy TM; Heppner Goss K; Scott MC; Witte DP; Groden J; Cohen MB
Biochem Biophys Res Commun; 2000 Jun; 273(1):225-30. PubMed ID: 10873591
[TBL] [Abstract][Full Text] [Related]
8. Intestinal immune responses in wild-type and Apcmin/+ mouse, a model for colon cancer.
Kettunen HL; Kettunen AS; Rautonen NE
Cancer Res; 2003 Aug; 63(16):5136-42. PubMed ID: 12941845
[TBL] [Abstract][Full Text] [Related]
9. Mapping of multiple intestinal neoplasia (Min) to proximal chromosome 18 of the mouse.
Luongo C; Gould KA; Su LK; Kinzler KW; Vogelstein B; Dietrich W; Lander ES; Moser AR
Genomics; 1993 Jan; 15(1):3-8. PubMed ID: 8094372
[TBL] [Abstract][Full Text] [Related]
10. Genetic mapping of Mom5, a novel modifier of Apc(Min)-induced intestinal tumorigenesis.
Oikarinen SI; Cleveland AG; Cork KM; Bynoté KK; Rafter JJ; Gustafsson JA; Mutanen M; Gould KA
Carcinogenesis; 2009 Sep; 30(9):1591-6. PubMed ID: 19574546
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional profiles of intestinal tumors in Apc(Min) mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumors.
Reichling T; Goss KH; Carson DJ; Holdcraft RW; Ley-Ebert C; Witte D; Aronow BJ; Groden J
Cancer Res; 2005 Jan; 65(1):166-76. PubMed ID: 15665292
[TBL] [Abstract][Full Text] [Related]
12. Mutations of the APC gene occur during early stages of gastric adenoma development.
Tamura G; Maesawa C; Suzuki Y; Tamada H; Satoh M; Ogasawara S; Kashiwaba M; Satodate R
Cancer Res; 1994 Mar; 54(5):1149-51. PubMed ID: 8118796
[TBL] [Abstract][Full Text] [Related]
13. Somatic mutational mechanisms involved in intestinal tumor formation in Min mice.
Shoemaker AR; Luongo C; Moser AR; Marton LJ; Dove WF
Cancer Res; 1997 May; 57(10):1999-2006. PubMed ID: 9157997
[TBL] [Abstract][Full Text] [Related]
14. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations in gastric adenomas of intestinal and foveolar phenotypes.
Abraham SC; Park SJ; Lee JH; Mugartegui L; Wu TT
Mod Pathol; 2003 Aug; 16(8):786-95. PubMed ID: 12920223
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of in vivo gene delivery by restriction enzyme PCR generated polymorphism.
Fichera A; Guo Y; Romero L; Michelassi F; Arenas RB
J Surg Res; 1997 Apr; 69(1):188-92. PubMed ID: 9202668
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors.
Miyaki M; Konishi M; Kikuchi-Yanoshita R; Enomoto M; Igari T; Tanaka K; Muraoka M; Takahashi H; Amada Y; Fukayama M
Cancer Res; 1994 Jun; 54(11):3011-20. PubMed ID: 8187091
[TBL] [Abstract][Full Text] [Related]
18. Intestinal tumours induced by the food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in multiple intestinal neoplasia mice have truncation mutations as well as loss of the wild-type Apc(+) allele.
Andreassen A ; Vikse R; Steffensen IL; Paulsen JE; Alexander J
Mutagenesis; 2001 Jul; 16(4):309-15. PubMed ID: 11420398
[TBL] [Abstract][Full Text] [Related]
19. Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse.
Song J; Medline A; Mason JB; Gallinger S; Kim YI
Cancer Res; 2000 Oct; 60(19):5434-40. PubMed ID: 11034085
[TBL] [Abstract][Full Text] [Related]
20. A frequent alteration of p53 gene in carcinoma in adenoma of colon.
Ohue M; Tomita N; Monden T; Fujita M; Fukunaga M; Takami K; Yana I; Ohnishi T; Enomoto T; Inoue M
Cancer Res; 1994 Sep; 54(17):4798-804. PubMed ID: 8062281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
